MoneyWorks4Me

Medicamen Biotech - Quaterly Results

29 May 2023 Evaluate
The turnover for the March 2023 quarter moved up 63.26% to Rs. 371.48 millions as compared to Rs. 227.54 millions during the year-ago period.Net Profit recorded in the quarter ended March 2023 rise to 46.97% to Rs. 40.46  millions  compared to R. 27.53 millions in corresponding previous quarter.Operating profit surged to 71.15 millions from the corresponding previous quarter of 53.15 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 371.48 227.54 63.26 1378.84 1154.45 19.44 1378.84 1154.45 19.44
Other Income 3.46 3.38 2.37 24.62 17.20 43.14 24.62 17.20 43.14
PBIDT 71.15 53.15 33.87 266.09 252.74 5.28 266.09 252.74 5.28
Interest 8.58 5.64 52.13 29.23 14.01 108.64 29.23 14.01 108.64
PBDT 62.57 47.51 31.70 236.86 238.73 -0.78 236.86 238.73 -0.78
Depreciation 16.10 15.24 5.64 63.54 57.71 10.10 63.54 57.71 10.10
PBT 46.47 32.27 44.00 173.32 181.02 -4.25 173.32 181.02 -4.25
TAX 6.01 4.74 26.79 23.31 31.97 -27.09 23.31 31.97 -27.09
Deferred Tax -4.74 -0.61 677.05 -13.69 -7.80 75.51 -13.69 -7.80 75.51
PAT 40.46 27.53 46.97 150.01 149.05 0.64 150.01 149.05 0.64
Equity 126.51 122.17 3.55 126.51 122.17 3.55 126.51 122.17 3.55
PBIDTM(%) 19.15 23.36 -18.00 19.30 21.89 -11.85 19.30 21.89 -11.85
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..